Phillips 66 (PSX) – Research Analysts’ Weekly Ratings Updates
Phillips 66 (NYSE: PSX) recently received a number of ratings updates from brokerages and research firms: 11/25/2025 – Phillips 66 had its price target raised by analysts at Raymond James Financial, Inc. from $153.00 to $169.00. They now have an “outperform” rating on the stock. 11/17/2025 – Phillips 66 had its price target raised by […]
Weekly Research Analysts’ Ratings Updates for The Hartford Insurance Group (HIG)
The Hartford Insurance Group (NYSE: HIG) recently received a number of ratings updates from brokerages and research firms: 11/25/2025 – The Hartford Insurance Group had its “buy (a-)” rating reaffirmed by analysts at Weiss Ratings. 11/25/2025 – The Hartford Insurance Group had its price target raised by analysts at Argus from $143.00 to $155.00. They […]
Analysts’ Weekly Ratings Updates for Targa Resources (TRGP)
Targa Resources (NYSE: TRGP) recently received a number of ratings updates from brokerages and research firms: 12/2/2025 – Targa Resources had its “buy” rating reaffirmed by analysts at UBS Group AG. 11/18/2025 – Targa Resources had its price target raised by analysts at Royal Bank Of Canada from $208.00 to $213.00. They now have an […]
Analysts’ Weekly Ratings Updates for BXP (BXP)
A number of research firms have changed their ratings and price targets for BXP (NYSE: BXP): 12/1/2025 – BXP had its price target lowered by analysts at Barclays PLC from $79.00 to $78.00. They now have an “equal weight” rating on the stock. 11/25/2025 – BXP had its price target lowered by analysts at Wells […]
Ford Motor (F) – Analysts’ Weekly Ratings Updates
Ford Motor (NYSE: F) has recently received a number of price target changes and ratings updates: 11/24/2025 – Ford Motor had its “buy (b-)” rating reaffirmed by analysts at Weiss Ratings. 11/24/2025 – Ford Motor had its price target raised by analysts at Evercore ISI from $10.00 to $12.00. They now have an “in-line” rating […]
Weekly Research Analysts’ Ratings Updates for Bio-Rad Laboratories (BIO)
Several brokerages have updated their recommendations and price targets on shares of Bio-Rad Laboratories (NYSE: BIO) in the last few weeks: 11/25/2025 – Bio-Rad Laboratories had its “sell (d-)” rating reaffirmed by analysts at Weiss Ratings. 11/22/2025 – Bio-Rad Laboratories was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” […]
Investment Analysts’ Weekly Ratings Updates for Ross Stores (ROST)
A number of firms have modified their ratings and price targets on shares of Ross Stores (NASDAQ: ROST) recently: 12/1/2025 – Ross Stores had its “buy” rating reaffirmed by analysts at Jefferies Financial Group Inc.. They now have a $205.00 price target on the stock. 11/21/2025 – Ross Stores had its price target raised by […]
FedEx (FDX) – Research Analysts’ Weekly Ratings Updates
Several analysts have recently updated their ratings and price targets for FedEx (NYSE: FDX): 12/1/2025 – FedEx had its price target raised by analysts at BMO Capital Markets from $255.00 to $265.00. They now have a “market perform” rating on the stock. 11/26/2025 – FedEx had its “hold (c+)” rating reaffirmed by analysts at Weiss […]
AvalonBay Communities (AVB) – Analysts’ Weekly Ratings Updates
Several brokerages have updated their recommendations and price targets on shares of AvalonBay Communities (NYSE: AVB) in the last few weeks: 11/25/2025 – AvalonBay Communities was upgraded by analysts at Barclays PLC from an “equal weight” rating to an “overweight” rating. They now have a $216.00 price target on the stock, down previously from $229.00. […]
Weekly Analysts’ Ratings Updates for NextEra Energy (NEE)
Several analysts have recently updated their ratings and price targets for NextEra Energy (NYSE: NEE): 12/1/2025 – NextEra Energy had its price target raised by analysts at Wolfe Research from $87.00 to $94.00. They now have an “outperform” rating on the stock. 11/24/2025 – NextEra Energy had its “hold (c+)” rating reaffirmed by analysts at […]
Weekly Investment Analysts’ Ratings Updates for LyondellBasell Industries (LYB)
Several brokerages have updated their recommendations and price targets on shares of LyondellBasell Industries (NYSE: LYB) in the last few weeks: 11/22/2025 – LyondellBasell Industries was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating. 11/19/2025 – LyondellBasell Industries had its price target lowered by analysts at Citigroup Inc. […]
Weekly Analysts’ Ratings Updates for Lam Research (LRCX)
Lam Research (NASDAQ: LRCX) recently received a number of ratings updates from brokerages and research firms: 11/25/2025 – Lam Research had its “buy” rating reaffirmed by analysts at UBS Group AG. They now have a $175.00 price target on the stock, up previously from $165.00. 11/24/2025 – Lam Research had its “buy (b)” rating reaffirmed […]
Arrowhead Pharmaceuticals (ARWR) – Investment Analysts’ Weekly Ratings Updates
A number of firms have modified their ratings and price targets on shares of Arrowhead Pharmaceuticals (NASDAQ: ARWR) recently: 11/26/2025 – Arrowhead Pharmaceuticals had its price target raised by analysts at Morgan Stanley from $45.00 to $48.00. They now have an “equal weight” rating on the stock. 11/20/2025 – Arrowhead Pharmaceuticals had its price target […]
Weekly Investment Analysts’ Ratings Updates for ODDITY Tech (ODD)
A number of firms have modified their ratings and price targets on shares of ODDITY Tech (NASDAQ: ODD) recently: 11/22/2025 – ODDITY Tech was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating. 11/21/2025 – ODDITY Tech had its price target lowered by analysts at JPMorgan Chase & Co. […]
Recent Investment Analysts’ Ratings Updates for Stoke Therapeutics (STOK)
Stoke Therapeutics (NASDAQ: STOK) has recently received a number of price target changes and ratings updates: 11/19/2025 – Stoke Therapeutics had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings. 11/19/2025 – Stoke Therapeutics was upgraded by analysts at Chardan Capital to a “strong-buy” rating. 11/13/2025 – Stoke Therapeutics had its “hold (c-)” rating […]
Recent Research Analysts’ Ratings Updates for MGE Energy (MGEE)
MGE Energy (NASDAQ: MGEE) has recently received a number of price target changes and ratings updates: 11/25/2025 – MGE Energy had its “hold (c+)” rating reaffirmed by analysts at Weiss Ratings. 11/19/2025 – MGE Energy was downgraded by analysts at Weiss Ratings from a “buy (b-)” rating to a “hold (c+)” rating. 11/13/2025 – MGE […]
Halozyme Therapeutics (HALO) – Research Analysts’ Weekly Ratings Updates
A number of firms have modified their ratings and price targets on shares of Halozyme Therapeutics (NASDAQ: HALO) recently: 11/19/2025 – Halozyme Therapeutics had its “buy (b)” rating reaffirmed by analysts at Weiss Ratings. 11/18/2025 – Halozyme Therapeutics had its price target raised by analysts at The Goldman Sachs Group, Inc. from $54.00 to $56.00. […]
Weekly Research Analysts’ Ratings Updates for Nutanix (NTNX)
Several brokerages have updated their recommendations and price targets on shares of Nutanix (NASDAQ: NTNX) in the last few weeks: 11/26/2025 – Nutanix had its price target lowered by analysts at Northland Securities from $76.00 to $53.00. They now have a “market perform” rating on the stock. 11/26/2025 – Nutanix had its price target lowered […]
Weekly Investment Analysts’ Ratings Updates for Trade Desk (TTD)
Trade Desk (NASDAQ: TTD) has recently received a number of price target changes and ratings updates: 11/25/2025 – Trade Desk had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings. 11/19/2025 – Trade Desk had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings. 11/13/2025 – Trade Desk had its “hold (c-)” rating […]
PTC Therapeutics (PTCT) – Investment Analysts’ Weekly Ratings Updates
PTC Therapeutics (NASDAQ: PTCT) recently received a number of ratings updates from brokerages and research firms: 11/25/2025 – PTC Therapeutics had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings. 11/19/2025 – PTC Therapeutics had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings. 11/13/2025 – PTC Therapeutics had its “hold (c)” rating […]
last updated on 2 Dec 23:08